Standard Guide for Visualization and Identification of Nanomaterials in Biological and Nonbiological Matrices Using Darkfield Microscopy/Hyperspectral Imaging (DFM/HSI) Analysis

SIGNIFICANCE AND USE
5.1 The information and recommendations in this guide are relevant for imaging and identifying ENMs in cells and other biological (for example, fixed tissues, whole plants) and nonbiological (for example, drug formulations, filter media, soil, and wastewater) matrices after appropriate sample preparation procedures have been performed (3-5). DFM/HSI is a recently developed analytical tool; however, the relative simplicity of sample preparation combined with the potential to acquire high-contrast ENM images and high-content ENM spectral responses facilitates the increasing use of the tool for diverse applications in drug delivery, toxicology, environmental science, biology, and medicine.  
5.2 Verification of the uptake and spatial distribution of ENMs in cells, for example, is necessary for evaluating and understanding the biological effects of ENMs on living systems. Similarly, the closeness of the spatial distribution of ENMs in complex drug formulations can be an important criterion in establishing physicochemical similarity between formulations (6). Complex products are described in the most recent version of the Generic Drug User Fee Act (GDUFA) reauthorization commitment letter: (7). This guide covers the criteria and general considerations for performing DFM/HSI analyses on samples of biological and nonbiological origins containing ENMs (for example, metal and metal oxide nanoparticles, or carbon nanotubes, or both). This guide does not cover or address provisions for imaging or identifying, or both, non-engineered (natural) nanoparticles/nanomaterials in cells or other matrices, nor does this guide describe or discuss the application of DFM/HSI for determining the dimensions of ENMs.
SCOPE
1.1 This guide has been prepared to familiarize laboratory scientists with the background information and technical content necessary to image and identify engineered nanomaterials (ENMs) in cells via darkfield microscopy/hyperspectral imaging (DFM/HSI) methodology.  
1.2 DFM/HSI is a hyphenated bioanalytical technique/tool that combines optical microscopy with high-resolution spectral imaging to both spatially localize the distribution of and identify ENMs within a suitably prepared test sample.  
1.2.1 In the context of mammalian cells, ENMs will have distinctive light-scattering properties in comparison to subcellular organelles and cell structural features, which can allow one to discriminate between the spectral profiles of ENMs and cellular components.  
1.2.2 The light-scattering properties of ENMs in other test samples, such as fixed tissues, plants, complex drug product formulations, filter media, and so forth, will also be different from the native matrix component scattering signals inherent to these other types of samples, thus allowing for ENM visualization and identification.  
1.3 This guide is applicable to the use of DFM/HSI for identifying ENMs in the matrices mentioned.  
1.4 This guide describes and discusses basic practices for setting up and using DFM/HSI instrumentation, sample imaging techniques, considerations for optics, image analysis, and the use of reference spectral libraries (RSLs). DFM/HSI is routinely used in industry, academia, and government as a research and development and quality control tool in diverse areas of nanotechnology.  
1.5 The values stated in SI units are to be regarded as the standard. No other units of measurement are included in this standard.  
1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.  
1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of Internati...

General Information

Status
Published
Publication Date
31-May-2021
Technical Committee
Current Stage
Ref Project

Buy Standard

Guide
ASTM E3275-21 - Standard Guide for Visualization and Identification of Nanomaterials in Biological and Nonbiological Matrices Using Darkfield Microscopy/Hyperspectral Imaging (DFM/HSI) Analysis
English language
17 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation:E3275 −21
Standard Guide for
Visualization and Identification of Nanomaterials in
Biological and Nonbiological Matrices Using Darkfield
1
Microscopy/Hyperspectral Imaging (DFM/HSI) Analysis
This standard is issued under the fixed designation E3275; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision.Anumber in parentheses indicates the year of last reapproval.A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope 1.6 This standard does not purport to address all of the
safety concerns, if any, associated with its use. It is the
1.1 This guide has been prepared to familiarize laboratory
responsibility of the user of this standard to establish appro-
scientists with the background information and technical con-
priate safety, health, and environmental practices and deter-
tent necessary to image and identify engineered nanomaterials
mine the applicability of regulatory limitations prior to use.
(ENMs) in cells via darkfield microscopy/hyperspectral imag-
1.7 This international standard was developed in accor-
ing (DFM/HSI) methodology.
dance with internationally recognized principles on standard-
1.2 DFM/HSI is a hyphenated bioanalytical technique/tool
ization established in the Decision on Principles for the
thatcombinesopticalmicroscopywithhigh-resolutionspectral
Development of International Standards, Guides and Recom-
imaging to both spatially localize the distribution of and
mendations issued by the World Trade Organization Technical
identify ENMs within a suitably prepared test sample.
Barriers to Trade (TBT) Committee.
1.2.1 In the context of mammalian cells, ENMs will have
distinctive light-scattering properties in comparison to subcel-
2. Referenced Documents
lular organelles and cell structural features, which can allow
2
2.1 ASTM Standards:
one to discriminate between the spectral profiles of ENMs and
E2456Terminology Relating to Nanotechnology
cellular components.
E3255Practice for Quality Assurance of Forensic Science
1.2.2 The light-scattering properties of ENMs in other test
ServiceProvidersPerformingForensicChemicalAnalysis
samples, such as fixed tissues, plants, complex drug product
3
2.2 ISO Standards:
formulations, filter media, and so forth, will also be different
ISO 20473Optics and photonics—Spectral bands
fromthenativematrixcomponentscatteringsignalsinherentto
ISO/TS 80004-1Nanotechnologies—Vocabulary—Part 1:
these other types of samples, thus allowing for ENM visual-
Core terms
ization and identification.
1.3 This guide is applicable to the use of DFM/HSI for
3. Terminology
identifying ENMs in the matrices mentioned.
3.1 Definitions:
1.4 This guide describes and discusses basic practices for
3.1.1 agglomerate, n—group of particles held together by
setting up and using DFM/HSI instrumentation, sample imag-
relatively weak forces (for example, van der Waals or capil-
ing techniques, considerations for optics, image analysis, and
lary) that may break apart into smaller particles upon
the use of reference spectral libraries (RSLs). DFM/HSI is
processing. E2456
routinely used in industry, academia, and government as a
3.1.2 aggregate, n—discrete group of particles in which the
research and development and quality control tool in diverse
various individual components are not easily broken apart,
areas of nanotechnology.
such as the case of primary particles that are strongly bonded
1.5 The values stated in SI units are to be regarded as the
together (for example, fused, sintered, or metallically bonded
standard. No other units of measurement are included in this
particles). E2456
standard.
2
For referenced ASTM standards, visit the ASTM website, www.astm.org, or
1
This guide is under the jurisdiction of ASTM Committee E56 on Nanotech- contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
nology and is the direct responsibility of Subcommittee E56.08 on Nano-Enabled Standards volume information, refer to the standard’s Document Summary page on
Medical Products. the ASTM website.
3
Current edition approved June 1, 2021. Published July 2021. DOI: 10.1520/ Available fromAmerican National Standards Institute (ANSI), 25 W. 43rd St.,
E3275-21. 4th Floor, New York, NY 10036, http://www.ansi.org.
Copyright © ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States
1

---------------------- Page: 1 ----------------------
E3275−21
3.1.3 blank sample, n—sample matrix carried through all or 3.1.16 image cube, n—hyperspectral image composed of
part of the analytical process, where
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.